SA
Sign upLog In
NVDA

NVDA Tangible Book Value Per Share

8.47TTM

Retrieved:

QuarterlyAnnualTTMChart Studio →
NVDA FY Tangible Book Value per Share
NVDA FY Tangible Book Value per Share1999-01-31: 0.002000-01-30: 0.012001-01-28: 0.022002-01-27: 0.042003-01-26: 0.052004-01-25: 0.052005-01-30: 0.052006-01-29: 0.072007-01-28: 0.082008-01-31: 0.102009-01-25: 0.092010-01-31: 0.102011-01-30: 0.112012-01-29: 0.132013-01-27: 0.162014-01-26: 0.152015-01-25: 0.162016-01-31: 0.172017-01-29: 0.232018-01-28: 0.282019-01-27: 0.362020-01-26: 0.472021-01-31: 0.402022-01-30: 0.802023-01-29: 0.652024-01-28: 1.522025-01-26: 2.992026-01-25: 5.475.470.00
1999-01-312026-01-25

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

NVDA tangible book value per share history

Tangible equity divided by shares outstanding. The available annual fiscal periods series contains 28 observations from Jan 31, 1999 to Jan 25, 2026.

Nvidia Tangible Book Value Per Share — Annual fiscal periods
Period endingTangible Book Value Per Share
5.4664
2.9864
1.5162
0.6455
0.7982
0.4037
0.4736
0.3569
0.2838
0.2329
0.1697
0.162
0.1496
0.1564
0.1316
0.1097
0.0989
0.0856
0.098
0.0785
0.0656
0.0523
0.0467
0.0465
0.0398
0.0244
0.0087
0.0049

Compare tangible book value per share

All NVDA financial metrics · NVDA stock overview · How to interpret financial metrics

Explore More

Technology Stocks

More Technology stocks

NVDA vs AAPL

Compare NVDA and AAPL side by side

NVDA vs MSFT

Compare NVDA and MSFT side by side

52-Week Highs Breakout

Stocks breaking to new annual highs

52-Week Lows Oversold

S&P 500 oversold value screener

Trending Momentum

Relative strength momentum leaders

Earnings Calendar

Upcoming earnings dates & reports

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.